These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine. Malone JI; Lowitt S; Corsico N; Orfalian Z Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404 [TBL] [Abstract][Full Text] [Related]
3. Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals. Di Giulio AM; Gorio A; Bertelli A; Mantegazza P; Ferraris L; Ramacci MT Int J Clin Pharmacol Res; 1992; 12(5-6):243-6. PubMed ID: 1284499 [TBL] [Abstract][Full Text] [Related]
4. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Saini AK; Kumar H S A; Sharma SS Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626 [TBL] [Abstract][Full Text] [Related]
5. Morphological and electrophysiological changes of peripheral nerve-muscle unit in the aged rat prevented by levocarnitine acetyl. Scarfò C; Falcinelli M; Pacifici L; Bellucci A; Reda E; De Angelis C; Ramacci MT; Angelucci L Int J Clin Pharmacol Res; 1992; 12(5-6):253-62. PubMed ID: 1301406 [TBL] [Abstract][Full Text] [Related]
6. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy. Sharma SS; Sayyed SG Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909 [TBL] [Abstract][Full Text] [Related]
7. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Sayyed SG; Kumar A; Sharma SS Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090 [TBL] [Abstract][Full Text] [Related]
8. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor. Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806 [TBL] [Abstract][Full Text] [Related]
9. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270 [TBL] [Abstract][Full Text] [Related]
10. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Nangle MR; Gibson TM; Cotter MA; Cameron NE Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532 [TBL] [Abstract][Full Text] [Related]
11. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Hasegawa T; Kosaki A; Shimizu K; Matsubara H; Mori Y; Masaki H; Toyoda N; Inoue-Shibata M; Nishikawa M; Iwasaka T Exp Neurol; 2006 Jun; 199(2):274-80. PubMed ID: 16337192 [TBL] [Abstract][Full Text] [Related]
12. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948 [TBL] [Abstract][Full Text] [Related]
14. The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy. Zochodne DW; Ho LT Can J Neurol Sci; 1992 Nov; 19(4):433-41. PubMed ID: 1423041 [TBL] [Abstract][Full Text] [Related]
15. Levocarnitine acetyl stimulates peripheral nerve regeneration and neuromuscular junction remodelling following sciatic nerve injury. De Angelis C; Scarfò C; Falcinelli M; Reda E; Ramacci MT; Angelucci L Int J Clin Pharmacol Res; 1992; 12(5-6):269-79. PubMed ID: 1338731 [TBL] [Abstract][Full Text] [Related]
16. Ganglioside therapy in experimental diabetic neuropathy. Spüler M; Dimpfel W; Tüllner HU Arzneimittelforschung; 1988 Jul; 38(7):881-4. PubMed ID: 3207433 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy. Bianchi R; Cervellini I; Porretta-Serapiglia C; Oggioni N; Burkey B; Ghezzi P; Cavaletti G; Lauria G J Pharmacol Exp Ther; 2012 Jan; 340(1):64-72. PubMed ID: 21984837 [TBL] [Abstract][Full Text] [Related]
18. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455 [TBL] [Abstract][Full Text] [Related]
19. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes. Cameron NE; Cotter MA Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E. Skalska S; Kyselova Z; Gajdosikova A; Karasu C; Stefek M; Stolc S Gen Physiol Biophys; 2008 Jun; 27(2):106-14. PubMed ID: 18645225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]